Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

Dysmenorrhea Market Regional Analysis

North America, particularly United States and Canada, is anticipated to lead the dysmenorrhea market share in the forecast period. The high prevalence of the condition in the region is a major aspect of the market size as women leading a sedentary lifestyle and following unhealthy dietary habits are more susceptible to develop the condition. In addition, the well-structured medical ecosystem facilitates easy availability of over the counter (OTC) pain relief medications, which further fuels the market share.

 

In Europe, there is a typically higher awareness of women’s health issues along with a well-developed healthcare infrastructure. Hence, it is a major player in the market. The market is currently witnessing a mix of both pharmaceutical as well as naturopathy therapies, as the population is inclining towards holistic homecare remedies for treating dysmenorrhea. Such cultural shifts will impact on the market value significantly in the forecast period.

 

The Asia Pacific dysmenorrhea market growth is driven by the increasing prevalence of traditional medicine and herbal remedies to treat the condition. With a substantial part of the population suffering from dysmenorrhea, several non-profit organizations and prominent healthcare companies are setting up essential awareness campaigns to educate the rural community about the disease. Alternatively, there have been significant efforts to improve the healthcare infrastructure as well.

 

Dysmenorrhea Market Report Snapshots

Dysmenorrhea Market Size

Dysmenorrhea Market Regional Analysis

Dysmenorrhea Treatment Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032, driven by the growing incidence of uterine fibroids, endometriosis and adenomyosis.

The market demand is driven by increased interest in improving women’s reproductive health with natural remedies and technological innovations in healthcare.

The major market trend revolves around the rising application of combination treatment methods to treat dysmenorrhea. Oral contraceptive pills are being tested as a potential intervention and have demonstrated positive results in management. There is growing investigations in developing better surgical management methods as well.

Based on treatment types, the market is divided into non-steroidal anti-inflammatory drugs (NSAIDs) and hormonal therapy.
Who are the major end users in the market?
Major end users include hospitals, homecare, and speciality clinics.

It includes primary and secondary dysmenorrhea.

The major regions of the market include the United States, Japan, EU-4 which is segmented into Germany, France, Italy, Spain, and the United Kingdom.

Key players involved in the market are Novartis AG, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline PLC, Focus Consumer Healthcare, Johnson & Johnson, Alvogen, Amgen Inc., Boehringer Ingelheim International GmbH., Ipsen Pharm, Spectrum Pharmaceuticals, Inc., and Takeda Pharmaceutical Company Limited.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear = calculateFutureValue(($getReportDetail['base_value'] > 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>